Rezolute Inc
NASDAQ:RZLT
Rezolute Inc Stock, NASDAQ:RZLT
201 Redwood Shores Parkway, Suite 315, Redwood City, California 94065
United States of America
Phone: +1.650.206.4507
Number of Employees: 23
Description
Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.